Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost

South Africa

Reference ID

SafetyEffectivenessandImmunogenicityofheterologousmRNA-1273Boost

Producer(s)

Nigel Garrett, Tarylee Reddy, Nonhlanhla Yende-Zuma, Azwidhwi Takalani, Kubashni Woeber, Annie Bodenstein, Phumeza Jonas, Imke Engelbrecht, Waasila Jassat, Harry Moultrie, Debbie Bradshaw, Ishen Seocharan, Jackline Odhiambo, Kentse Khuto, Simone I. Richardson, Millicent A. Omondi, Rofhiwa Nesamari,

Metadata

Documentation in PDF DDI/XML JSON

Created on

Apr 29, 2024

Last modified

Apr 29, 2024

Page views

25323

Downloads

type_diagnosis (type_diagnosis)

Data file: SHERPA_Safetydata

Overview

Valid: 343

Invalid: 0

Type: Discrete

Width: 18

Range: -

Format: character

Questions and instructions

Categories

Value	Cases
Other	1	0.3%
PCR Test	338	98.5%
Rapid Antigen Test	4	1.2%

Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.

Back to Catalog